Screener
Baxter International BAX Pharmaceuticals — Cost of Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Baxter International’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:50 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028962
| (in millions) | Three Months Ended March 31, 2026 / Medical Products & Therapies | Three Months Ended March 31, 2026 / Healthcare Systems & Technologies | Three Months Ended March 31, 2026 / Pharmaceuticals | Three Months Ended March 31, 2025 / Medical Products & Therapies | Three Months Ended March 31, 2025 / Healthcare Systems & Technologies | Three Months Ended March 31, 2025 / Pharmaceuticals |
|---|---|---|---|---|---|---|
| Net sales | $1,285 | $705 | $621 | $1,262 | $704 | $581 |
| Cost of sales | 781 | 390 | 458 | 694 | 356 | 396 |
| Selling, general and administrative expenses | 290 | 209 | 102 | 286 | 217 | 103 |
| Research and development expenses | 54 | 49 | 22 | 59 | 45 | 26 |
| Other segment items | (26) | (9) | (7) | (21) | (7) | (7) |
| Segment operating income | $186 | $66 | $46 | $244 | $93 | $63 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Baxter International's pharmaceuticals — cost of sales?
- Baxter International (BAX) reported pharmaceuticals — cost of sales of $458M in Q1 2026.
- How has Baxter International's pharmaceuticals — cost of sales changed year-over-year?
- Baxter International's pharmaceuticals — cost of sales increased by 15.7% year-over-year, from $396M to $458M.
- What is the long-term trend for Baxter International's pharmaceuticals — cost of sales?
- Over 3 years (2022 to 2025), Baxter International's pharmaceuticals — cost of sales has grown at a 11.2% compound annual growth rate (CAGR), from $1.29B to $1.78B.
- What does pharmaceuticals — cost of sales mean?
- Includes all direct costs associated with the production and delivery of pharmaceutical products, such as raw materials, manufacturing labor, and overhead. Monitoring this helps evaluate the segment's production efficiency and gross margin potential.
Ask your AI about Baxter International's pharmaceuticals — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude